Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: SICAV
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: International

Parvest Equity World Health Care

+ Add to Watchlist

FOREPWI:LX

1,157.10 EUR

As of 00:59:30 ET on 05/26/2015.

Snapshot for Parvest Equity World Health Care (FOREPWI)

Year To Date: +26.58% 3-Month: +9.02% 3-Year: +35.67% 52-Week Range: 722.20 - 1,180.43
1-Month: -1.27% 1-Year: +62.23% 5-Year: +25.61% Beta vs MN40WHCU: 1.11

Mutual Fund Chart for FOREPWI

No chart data available.
  • FOREPWI:LX 1,157.10
  • 1M
  • 1Y
Interactive FOREPWI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for FOREPWI

Parvest Equity World Health Care is a SICAV incorporated in Luxembourg. The Fund invests at least two-thirds of its assets in shares representing the capital of companies throughout the world involved in the health care and related sectors, and any other type of securities relating to such companies or sectors.

Inception Date: 03-20-2008 Telephone: 32-2-274-93-11
Managers: CHRISTIAN FAY
Web Site: www.bnpparibas-ip.com

Fundamentals for FOREPWI

NAV (on 2015-05-26) 1,157.10
Assets (M) (on 2015-05-22) 446.58
Fund Leveraged N
Minimum Investment 0.00
Minimum Subsequent Investment 0.00

Dividends for FOREPWI

No dividends reported

Fees & Expenses for FOREPWI

Front Load -
Back Load 0.00
Current Mgmt Fee 0.60
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 0.79

Top Fund Holdings for FOREPWI

Filing Date: 12/31/2014
Name Position Value % of Total
AbbVie Inc 319,248 17,265,063 4.455%
Roche Holding AG 69,568 15,616,421 4.029%
Celgene Corp 166,619 15,402,670 3.974%
Johnson & Johnson 166,259 14,367,756 3.707%
Merck & Co Inc 292,564 13,730,598 3.543%
Gilead Sciences Inc 176,248 13,729,298 3.542%
Actavis plc 64,022 13,619,192 3.514%
Pfizer Inc 489,733 12,607,068 3.253%
Bayer AG 102,276 11,557,188 2.982%
Novartis AG 131,683 10,114,297 2.610%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil